INC Research Holdings Company Profile (NASDAQ:INCR)

About INC Research Holdings (NASDAQ:INCR)

INC Research Holdings logoINC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INCR
  • CUSIP: N/A
  • Web: www.incresearch.com
Capitalization:
  • Market Cap: $3.01 billion
  • Outstanding Shares: 54,181,000
Average Prices:
  • 50 Day Moving Avg: $54.48
  • 200 Day Moving Avg: $53.91
  • 52 Week Range: $40.65 - $61.10
P/E:
  • Trailing P/E Ratio: 33.52
  • Foreward P/E Ratio: 17.69
  • P/E Growth: 1.16
Sales & Book Value:
  • Annual Revenue: $1.03 billion
  • Price / Sales: 2.92
  • Book Value: $6.52 per share
  • Price / Book: 8.52
Profitability:
  • EBITDA: $226.74 million
  • Net Margins: 5.69%
  • Return on Equity: 40.69%
  • Return on Assets: 9.87%
Debt:
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.15%
  • Quick Ratio: 1.15%
Misc:
  • Average Volume: 780,548 shs.
  • Beta: 1.34
  • Short Ratio: 4.84
 

Frequently Asked Questions for INC Research Holdings (NASDAQ:INCR)

What is INC Research Holdings' stock symbol?

INC Research Holdings trades on the NASDAQ under the ticker symbol "INCR."

How were INC Research Holdings' earnings last quarter?

INC Research Holdings, Inc. (NASDAQ:INCR) announced its quarterly earnings data on Thursday, July, 27th. The company reported $0.64 EPS for the quarter, hitting the Zacks' consensus estimate of $0.64. The firm earned $258.10 million during the quarter, compared to analyst estimates of $256.76 million. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The company's revenue was down .3% on a year-over-year basis. During the same period last year, the company earned $0.61 earnings per share. View INC Research Holdings' Earnings History.

When will INC Research Holdings make its next earnings announcement?

INC Research Holdings is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for INC Research Holdings.

Where is INC Research Holdings' stock going? Where will INC Research Holdings' stock price be in 2017?

10 brokerages have issued 12-month target prices for INC Research Holdings' stock. Their predictions range from $57.00 to $69.00. On average, they anticipate INC Research Holdings' share price to reach $65.00 in the next year. View Analyst Ratings for INC Research Holdings.

Who are some of INC Research Holdings' key competitors?

Who are INC Research Holdings' key executives?

INC Research Holdings' management team includes the folowing people:

  • Michael A. Bell, Executive Chairman of the Board, President - Commercial Division
  • Alistair Macdonald, Chief Executive Officer, Director
  • Gregory S. Rush, Chief Financial Officer, Executive Vice President
  • Christopher L. Gaenzle, Chief Administrative Officer, General Counsel, Secretary
  • David York Norton, Non-Executive Independent Chairman of the Board
  • Todd Abbrecht, Director
  • Tom Allen, Director
  • Joshua Nelson, Director
  • Robert W. Breckon, Independent Director

How do I buy INC Research Holdings stock?

Shares of INC Research Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is INC Research Holdings' stock price today?

One share of INC Research Holdings stock can currently be purchased for approximately $55.55.


MarketBeat Community Rating for INC Research Holdings (NASDAQ INCR)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  293
MarketBeat's community ratings are surveys of what our community members think about INC Research Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for INC Research Holdings (NASDAQ:INCR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $65.00 (17.01% upside)
Consensus Price Target History for INC Research Holdings (NASDAQ:INCR)
Price Target History for INC Research Holdings (NASDAQ:INCR)
Analysts' Ratings History for INC Research Holdings (NASDAQ:INCR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/11/2017Credit Suisse GroupInitiated CoverageOutperform$68.00N/AView Rating Details
10/9/2017Jefferies Group LLCUpgradeHold -> Buy$62.50 -> $69.00N/AView Rating Details
10/9/2017Robert W. BairdReiterated RatingBuy$67.00N/AView Rating Details
9/21/2017MizuhoInitiated CoverageNeutral$57.00LowView Rating Details
8/7/2017Goldman Sachs Group, Inc. (The)Reiterated RatingBuy -> Buy$65.00LowView Rating Details
6/20/2017William BlairDowngradeOutperform -> Market PerformHighView Rating Details
6/5/2017KeyCorpUpgradeSector Weight -> Overweight$68.00LowView Rating Details
5/31/2017SunTrust Banks, Inc.UpgradeHold -> Buy$48.00 -> $67.00MediumView Rating Details
5/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformHighView Rating Details
12/19/2016First AnalysisInitiated CoverageEqual -> Equal Weight$59.00N/AView Rating Details
4/18/2016Avondale PartnersBoost Price TargetMarket Perform$39.00 -> $47.00N/AView Rating Details
3/24/2016J P Morgan Chase & CoInitiated CoverageOverweight$47.00N/AView Rating Details
(Data available from 10/19/2015 forward)

Earnings

Earnings History for INC Research Holdings (NASDAQ:INCR)
Earnings by Quarter for INC Research Holdings (NASDAQ:INCR)
Earnings History by Quarter for INC Research Holdings (NASDAQ INCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$0.68N/AView Earnings Details
7/27/2017Q2 2017$0.64$0.64$256.76 million$258.10 millionViewN/AView Earnings Details
5/10/2017Q1 2017$0.55$0.60$250.76 million$252.10 millionViewN/AView Earnings Details
2/28/2017Q4 2016$0.67$0.67$269.00 million$263.00 millionViewListenView Earnings Details
10/31/2016Q316$0.59$0.64$259.89 million$259.56 millionViewListenView Earnings Details
7/27/2016Q216$0.58$0.61$252.39 million$258.80 millionViewListenView Earnings Details
5/2/2016Q116$0.53$0.58$237.78 million$249.00 millionViewListenView Earnings Details
2/25/2016Q415$0.49$0.54$239.31 million$241.40 millionViewListenView Earnings Details
10/29/2015Q3$0.44$0.58$230.60 million$234.50 millionViewListenView Earnings Details
7/30/2015Q215$0.34$0.47$219.08 million$227.40 millionViewListenView Earnings Details
4/27/2015Q115$0.26$0.41$211.20 million$308.90 millionViewListenView Earnings Details
2/24/2015Q414$0.21$0.24$207.88 million$213.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for INC Research Holdings (NASDAQ:INCR)
2017 EPS Consensus Estimate: $2.54
2018 EPS Consensus Estimate: $2.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.56$0.64$0.61
Q2 20173$0.56$0.64$0.60
Q3 20174$0.57$0.65$0.62
Q4 20175$0.65$0.75$0.71
Q1 20181$0.61$0.61$0.61
Q2 20182$0.65$0.72$0.69
Q3 20181$0.72$0.72$0.72
Q4 20181$0.77$0.77$0.77
(Data provided by Zacks Investment Research)

Dividends

Dividend History for INC Research Holdings (NASDAQ:INCR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for INC Research Holdings (NASDAQ:INCR)
Insider Ownership Percentage: 0.24%
Institutional Ownership Percentage: 54.57%
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)
Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Alistair MacdonaldCEOSell2,348$54.60$128,200.80View SEC Filing  
9/18/2017Christopher L GaenzleCAOSell4,682$54.56$255,449.92View SEC Filing  
9/18/2017Gregory S RushCFOSell9,703$54.48$528,619.44View SEC Filing  
9/1/2017Christopher L GaenzleCAOSell42,601$58.67$2,499,400.67View SEC Filing  
9/1/2017Gregory S RushCFOSell88,739$58.99$5,234,713.61View SEC Filing  
8/30/2017Gregory S RushCFOSell41,420$58.26$2,413,129.20View SEC Filing  
8/17/2017Alistair MacdonaldCEOSell8,828$55.65$491,278.20View SEC Filing  
7/3/2017Alistair MacdonaldCEOSell10,555$58.38$616,200.90View SEC Filing  
6/30/2017Christopher L GaenzleCAOSell6,873$58.32$400,833.36View SEC Filing  
5/1/2017Alistair MacdonaldCEOSell9,467$45.00$426,015.00View SEC Filing  
4/3/2017Christopher L GaenzleCAOSell4,733$45.70$216,298.10View SEC Filing  
3/3/2017Alistair MacdonaldCEOSell8,828$45.00$397,260.00View SEC Filing  
1/20/2017Alistair MacdonaldCEOSell1,375$50.50$69,437.50View SEC Filing  
1/20/2017Christopher L GaenzleCAOSell1,186$50.09$59,406.74View SEC Filing  
1/19/2017Gregory S RushVPSell2,907$50.57$147,006.99View SEC Filing  
1/5/2017Alistair MacdonaldCEOSell14,840$52.19$774,499.60View SEC Filing  
9/30/2016Gregory S RushVPSell35,503$44.70$1,586,984.10View SEC Filing  
9/27/2016D. Jamie MacdonaldCEOSell53,970$44.30$2,390,871.00View SEC Filing  
9/26/2016Robert W BreckonDirectorSell12,197$44.16$538,619.52View SEC Filing  
9/19/2016David F BurgstahlerDirectorBuy1,000$43.19$43,190.00View SEC Filing  
9/14/2016Christopher L GaenzleCAOSell4,734$43.14$204,224.76View SEC Filing  
8/17/2016Alistair MacdonaldCOOSell8,828$43.80$386,666.40View SEC Filing  
8/4/2016Avista Capital Partners Ii Gp,Major ShareholderSell2,554,409$42.06$107,438,442.54View SEC Filing  
8/4/2016Teachers Pension Plan OntarioDirectorSell2,445,591$42.06$102,861,557.46View SEC Filing  
8/2/2016D. Jamie MacdonaldCEOSell31,279$43.00$1,344,997.00View SEC Filing  
8/1/2016Robert W BreckonDirectorSell108$42.00$4,536.00View SEC Filing  
7/28/2016Gregory S RushVPSell4,066$45.23$183,905.18View SEC Filing  
7/20/2016D. Jamie MacdonaldCEOSell100,593$43.00$4,325,499.00View SEC Filing  
7/15/2016Gregory S RushCFOSell5,917$41.50$245,555.50View SEC Filing  
7/11/2016Alistair MacdonaldCOOSell9,468$40.19$380,518.92View SEC Filing  
7/11/2016Christopher L GaenzleCAOSell21,918$40.20$881,103.60View SEC Filing  
7/1/2016Gregory S RushCFOSell1,358$37.97$51,563.26View SEC Filing  
7/1/2016Robert W BreckonDirectorSell421$37.97$15,985.37View SEC Filing  
6/15/2016Christopher L GaenzleCAOSell7,702$40.14$309,158.28View SEC Filing  
6/6/2016Michael GibertiniInsiderSell213,966$43.11$9,224,074.26View SEC Filing  
6/2/2016Robert W BreckonDirectorSell11,691$43.53$508,909.23View SEC Filing  
5/6/2016Avista Capital Partners Ii Gp,Major ShareholderSell4,087,054$45.12$184,407,876.48View SEC Filing  
5/6/2016Teachers Pension Plan OntarioDirectorSell3,912,946$45.12$176,552,123.52View SEC Filing  
4/18/2016James T OgleDirectorSell114,806$50.00$5,740,300.00View SEC Filing  
4/12/2016D. Jamie MacdonaldCEOSell94,675$48.00$4,544,400.00View SEC Filing  
4/1/2016Michael GibertiniInsiderSell9,000$40.78$367,020.00View SEC Filing  
3/1/2016Michael GibertiniInsiderSell9,000$39.85$358,650.00View SEC Filing  
2/4/2016Robert W. BreckonDirectorSell3,882$40.03$155,396.46View SEC Filing  
2/1/2016Gregory S. RushCFOSell17,752$40.27$714,873.04View SEC Filing  
2/1/2016Michael GibertiniinsiderSell9,000$40.57$365,130.00View SEC Filing  
1/4/2016Michael GibertiniinsiderSell9,000$46.83$421,470.00View SEC Filing  
12/31/2015Alistair MacdonaldCOOSell159,599$47.46$7,574,568.54View SEC Filing  
12/31/2015Christopher L. GaenzleCAOSell9,468$48.18$456,168.24View SEC Filing  
12/31/2015Gregory S. RushCFOSell35,503$48.17$1,710,179.51View SEC Filing  
12/29/2015James T. OgleDirectorSell9,717$50.06$486,433.02View SEC Filing  
12/8/2015Christopher L. GaenzleCAOSell25,185$41.78$1,052,229.30View SEC Filing  
12/8/2015Gregory S. RushCFOSell81,035$45.13$3,657,109.55View SEC Filing  
12/7/2015Alistair MacdonaldCOOSell42,959$44.63$1,917,260.17View SEC Filing  
12/7/2015Avista Capital Partners Ii Gp,Major ShareholderSell4,597,937$45.00$206,907,165.00View SEC Filing  
12/7/2015Teachers Pension Plan OntarioDirectorSell4,402,063$45.00$198,092,835.00View SEC Filing  
12/1/2015Michael GibertiniinsiderSell9,000$46.52$418,680.00View SEC Filing  
11/2/2015Michael GibertiniinsiderSell9,000$41.70$375,300.00View SEC Filing  
9/28/2015Alistair MacdonaldCOOSell44,522$39.93$1,777,763.46View SEC Filing  
9/14/2015Gregory S. RushCFOSell32,426$45.06$1,461,115.56View SEC Filing  
8/31/2015Christopher L. GaenzleCAOSell17,421$41.16$717,048.36View SEC Filing  
8/31/2015James T OgleDirectorSell55,000$41.12$2,261,600.00View SEC Filing  
8/17/2015Avista Capital Partners Ii Gp,Major ShareholderSell4,029,168$44.00$177,283,392.00View SEC Filing  
8/17/2015Teachers Pension Plan OntarioDirectorSell3,857,525$44.00$169,731,100.00View SEC Filing  
8/12/2015D. Jamie MacdonaldCEOSell57,021$44.00$2,508,924.00View SEC Filing  
8/12/2015Robert W BreckonDirectorSell8,381$44.00$368,764.00View SEC Filing  
5/14/2015Avista Capital Partners Ii Gp,Major ShareholderSell6,599,761$29.68$195,880,906.48View SEC Filing  
5/14/2015Teachers Pension Plan OntarioDirectorSell6,318,607$29.68$187,536,255.76View SEC Filing  
5/7/2015Gregory S RushCFOSell12,455$29.68$369,664.40View SEC Filing  
5/7/2015Michael GibertiniInsiderSell50,000$29.68$1,484,000.00View SEC Filing  
5/7/2015Robert W BreckonDirectorSell8,226$29.68$244,147.68View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for INC Research Holdings (NASDAQ:INCR)
Latest Headlines for INC Research Holdings (NASDAQ:INCR)
Source:
DateHeadline
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - October 19 at 1:00 AM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Now Covered by Credit Suisse Group
www.americanbankingnews.com - October 15 at 10:20 PM
americanbankingnews.com logoQ3 2017 Earnings Estimate for INC Research Holdings, Inc. Issued By Jefferies Group (INCR)
www.americanbankingnews.com - October 11 at 6:34 AM
finance.yahoo.com logoINC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : October 10, 2017
finance.yahoo.com - October 11 at 5:19 AM
benzinga.com logoThe INC Research Pullback Creates A Compelling Entry Point - Benzinga
www.benzinga.com - October 10 at 7:16 PM
streetinsider.com logoJefferies Upgrades INC Research Holdings (INCR) to Buy - StreetInsider.com
www.streetinsider.com - October 9 at 7:54 PM
finance.yahoo.com logoThe INC Research Pullback Creates A Compelling Entry Point
finance.yahoo.com - October 9 at 7:54 PM
americanbankingnews.com logoINC Research Holdings (INCR) vs. Idera Pharmaceuticals (IDRA) Head to Head Comparison
www.americanbankingnews.com - October 4 at 12:24 AM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Expected to Post Quarterly Sales of $586.58 Million
www.americanbankingnews.com - October 3 at 1:18 PM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Expected to Post Earnings of $0.62 Per Share
www.americanbankingnews.com - October 1 at 4:30 AM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 23 at 11:10 PM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Research Coverage Started at Mizuho
www.americanbankingnews.com - September 21 at 10:02 AM
americanbankingnews.com logoAlistair Macdonald Sells 2,348 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 19 at 8:08 PM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) CAO Christopher L. Gaenzle Sells 4,682 Shares
www.americanbankingnews.com - September 19 at 7:42 PM
americanbankingnews.com logoInsider Selling: INC Research Holdings, Inc. (INCR) CFO Sells 9,703 Shares of Stock
www.americanbankingnews.com - September 19 at 7:40 PM
americanbankingnews.com logo$586.58 Million in Sales Expected for INC Research Holdings, Inc. (INCR) This Quarter
www.americanbankingnews.com - September 14 at 8:20 AM
finance.yahoo.com logoStocks Generating Improved Relative Strength: IN Cresearch
finance.yahoo.com - September 12 at 1:33 AM
seekingalpha.com logoINC Research Holdings (INCR) Presents At Baird's 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - September 8 at 11:16 PM
finance.yahoo.com logoINC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : September 8, 2017
finance.yahoo.com - September 8 at 11:16 PM
seekingalpha.com logoINC Research Holdings (INCR) Presents At Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 7 at 8:07 PM
americanbankingnews.com logoGregory S. Rush Sells 88,739 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 5 at 10:26 PM
americanbankingnews.com logoInsider Selling: INC Research Holdings, Inc. (INCR) CAO Sells 42,601 Shares of Stock
www.americanbankingnews.com - September 5 at 7:23 PM
americanbankingnews.com logoGregory S. Rush Sells 41,420 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 1 at 7:22 PM
finance.yahoo.com logoIN Cresearch Sees RS Rating Improve To 73
finance.yahoo.com - August 30 at 1:28 AM
finance.yahoo.com logoINC Research Holdings, Inc. – Value Analysis (NASDAQ:INCR) : August 30, 2017
finance.yahoo.com - August 30 at 1:28 AM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 29 at 11:08 PM
americanbankingnews.com logo Brokerages Anticipate INC Research Holdings, Inc. (INCR) to Announce $0.62 Earnings Per Share
www.americanbankingnews.com - August 24 at 10:24 PM
finance.yahoo.com logoINC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : August 23, 2017
finance.yahoo.com - August 24 at 7:55 AM
americanbankingnews.com logoPortola Pharmaceuticals (PTLA) and INC Research Holdings (INCR) Head to Head Contrast
www.americanbankingnews.com - August 24 at 4:08 AM
americanbankingnews.com logoINC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 8,828 Shares
www.americanbankingnews.com - August 21 at 10:20 AM
americanbankingnews.com logoContrasting Arena Pharmaceuticals (ARNA) and INC Research Holdings (INCR)
www.americanbankingnews.com - August 18 at 8:10 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about INC Research Holdings Inc.
finance.yahoo.com - August 14 at 10:36 PM
finance.yahoo.com logoinVentiv Group Holdings, Inc. -- Moody's downgrades INC Research to Ba3; outlook stable
finance.yahoo.com - August 11 at 11:17 PM
finance.yahoo.com logoETFs with exposure to INC Research Holdings, Inc. : August 11, 2017
finance.yahoo.com - August 11 at 11:17 PM
thestreet.com logoSee How INC Research Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity
www.thestreet.com - August 11 at 3:59 AM
americanbankingnews.com logoINC Research Holdings, Inc. (NASDAQ:INCR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 4 at 10:38 PM
globenewswire.com logoINC Research and inVentiv Health Announce Successful Completion of Merger
globenewswire.com - August 1 at 3:27 PM
finance.yahoo.com logoDone deal: INC Research, inVentiv Health complete merger
finance.yahoo.com - August 1 at 3:27 PM
finance.yahoo.com logoFaruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against INC Research Holdings, Inc.
finance.yahoo.com - July 31 at 7:16 PM
americanbankingnews.com logoBrokers Offer Predictions for INC Research Holdings, Inc.'s Q2 2018 Earnings (INCR)
www.americanbankingnews.com - July 31 at 8:56 AM
americanbankingnews.com logoJefferies Group LLC Reaffirms Hold Rating for INC Research Holdings, Inc. (INCR)
www.americanbankingnews.com - July 30 at 11:38 AM
finance.yahoo.com logoINC Research Holdings, Inc. :INCR-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017
finance.yahoo.com - July 28 at 11:15 PM
americanbankingnews.com logoINC Research Holdings, Inc. (NASDAQ:INCR) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - July 28 at 12:20 AM
finance.yahoo.com logoINC Research Reports Second Quarter 2017 Results
finance.yahoo.com - July 27 at 10:37 PM
finance.yahoo.com logoEdited Transcript of INCR earnings conference call or presentation 27-Jul-17 12:00pm GMT
finance.yahoo.com - July 27 at 10:37 PM
finance.yahoo.com logoINC Research meets 2Q profit forecasts
finance.yahoo.com - July 27 at 10:37 PM
americanbankingnews.com logo$257.67 Million in Sales Expected for INC Research Holdings, Inc. (NASDAQ:INCR) This Quarter
www.americanbankingnews.com - July 19 at 3:46 PM
americanbankingnews.com logoComparing INC Research Holdings (INCR) & Nektar Therapeutics (NKTR)
www.americanbankingnews.com - July 16 at 4:24 PM
finance.yahoo.com logoINC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : July 14, 2017
finance.yahoo.com - July 15 at 2:15 AM
finance.yahoo.com logoStull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)
finance.yahoo.com - July 14 at 3:51 AM

Social

Chart

INC Research Holdings (INCR) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.